Healthcare Triangle, Inc.
For the period ended Mar 31, 2025. Filed May 20, 2025.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Mar 31, 2025 · Filed May 20, 2025
HCTI$4.21-0.2%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Unaudited Condensed Consolidated Balance sheets
Condensed Consolidated Balance Sheets
| March 31, | December 31, | |
|---|---|---|
| 2025 | 2024 | |
| (Unaudited) | ||
| Assets | ||
| Current assets | ||
| Cash and cash equivalents | $6,826 | $20 |
| Accounts receivable | 1,907 | 1,110 |
| Other current assets | 1,107 | 322 |
| Total current assets | 9,840 | 1,452 |
| Property and equipment, net | - | 12 |
| Due from affiliates | 1,945 | 497 |
| Total assets | $11,785 | $1,961 |
| Liabilities and stockholders’ equity (deficit) | ||
| Current liabilities | ||
| Accounts payable | $1,618 | $2,539 |
| Short term borrowing | 775 | 2,650 |
| Other current liabilities | 815 | 1,386 |
| Total current liabilities | 3,208 | 6,575 |
| Long-term liabilities | ||
| Contingent consideration | - | 500 |
| Total current and long-term liabilities | 3,208 | 7,075 |
| Stockholders’ equity | ||
| Preferred stock, par value $0.00001; 10,000,000 authorized Issued 1,600,000 as of March 31, 2025 and as of December 31, 2024 | 7,435 | 7,435 |
| Series A, Super Voting Preferred Stock - 20,000 shares (1,000 votes per share) | - | - |
| Common stock, par value $0.00001; 100,000,000 authorized 16,038,376 and 5,666,781 shares issued and outstanding as of March 31, 2025, and December 31, 2024 respectively | - | - |
| Additional paid-in capital | 36,413 | 21,022 |
| Accumulated deficit | (35,271) | (33,571) |
| Total stockholders’ equity (deficit) | 8,577 | (5,114) |
| Total liabilities and stockholders’ equity | $11,785 | $1,961 |
The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.